000 01388 a2200409 4500
005 20250515234847.0
264 0 _c20110801
008 201108s 0 0 eng d
022 _a1423-0216
024 7 _a10.1159/000317393
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMusabak, Ugur
245 0 0 _aSerum adiponectin, TNF-α, IL-12p70, and IL-13 levels in multiple sclerosis and the effects of different therapy regimens.
_h[electronic resource]
260 _bNeuroimmunomodulation
_c2011
300 _a57-66 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdiponectin
_xblood
650 0 4 _aAdult
650 0 4 _aCytokines
_xblood
650 0 4 _aDemyelinating Diseases
_xblood
650 0 4 _aFemale
650 0 4 _aFollow-Up Studies
650 0 4 _aHumans
650 0 4 _aInterleukin-12
_xblood
650 0 4 _aInterleukin-13
_xblood
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aMultiple Sclerosis
_xclassification
650 0 4 _aTumor Necrosis Factor-alpha
_xblood
650 0 4 _aYoung Adult
700 1 _aDemirkaya, Seref
700 1 _aGenç, Gencer
700 1 _aIlikci, Rahsan Sagkan
700 1 _aOdabasi, Zeki
773 0 _tNeuroimmunomodulation
_gvol. 18
_gno. 1
_gp. 57-66
856 4 0 _uhttps://doi.org/10.1159/000317393
_zAvailable from publisher's website
999 _c20050420
_d20050420